CAS: 50-55-5; Reserpine

该化合物是源于Rauwolfia 蛇状植物的单体藻类,通常以其在传统医学中的用途和抗血压剂而闻名,其特点是结构复杂,包括四环核心和甲氧基.该物质通常以盐的形式施用,如中脊盐酸,以相对半衰期闻名.除了其治疗应用外,还研究了其可能对心理健康紊乱产生的影响,尽管其使用由于新药的研发而减弱,包括了对气体的不利效应.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号482-98-4 Yohimban-16-met...

合成工艺路线路线简述

    Dimethyl (3As,4S,6R,7S,7As)-6-[tert-Butyl(Dimethyl)Silyl]Oxy-2-Hydroxy-7-Methoxy-3,3A,4,5,6,7-Hexahydro-2H-1-Benzofuran-4,7A-Dicarboxylate置于2,6-二甲基吡啶,4-二甲氨基吡啶,Samarium Diiodide,硼烷四氢呋喃络合物,氢氟酸,乙二醇,三乙胺,三甲基乙酸体系中,用 四氢呋喃,六甲基磷酰三胺,二氯甲烷,甲苯,乙腈,苯 作为反应溶剂,化学反应 21.67H,反应生成 利血平
    参考文献:使用chiron方法的(-)-利血平全合成.
    标题:使用chiron方法的(-)-利血平全合成.
    摘要:从(-)-奎宁酸作为手性模板开始,已开发了立体立体控制的利血平环d / E前体的合成方法.(-)-利血平的总合成通过内酰胺铵中间体的环化来描述.
    DOI:10.1021/jo961713W

    海关参考信息

    专利信息


    专利号:WO-2010103857-A1
    优先权日:2009-03-12
    标 题 :Method for solid-phase synthesis of glycopeptide using silicon-containing protecting group and synthesis device
    发明人:NISHIMURA SHIN-ICHIRO; SHIMAWAKI KEN
    权利人:UNIV HOKKAIDO NAT UNIV CORP; NISHIMURA SHIN-ICHIRO; SHIMAWAKI KEN
    摘要:Disclosed are a novel method for the synthesis of a glycopeptide by which glycopeptides of various types can be deprotected and excised from a resin, each under weakly acidic to weakly basic conditions, without causing the problems of the epimerization of an amino acid at the a-position and the ß-elimination of a sugar residue; a synthesis device therefor; and a synthesis intermediate to be used in synthesizing a glycopeptide. Specifically disclosed are a method for the solid-phase synthesis of a glycopeptide which comprises a step for obtaining a glycopeptide derivative wherein the N-terminus is protected, the C-terminus is immobilized to a solid phase via a silicon linker, and a reactive group carried by a sugar residue and a reactive group carried by an amino acid side chain constituting a peptide are protected by silicon-containing groups, and a step for obtaining the glycopeptide by deprotecting said glycopeptide derivative and releasing the same from the solid phase by treating the glycopeptide derivative with an agent for removing the silicon-containing groups and the silicon linker; a synthesis intermediate to be used in the step for obtaining the glycopeptide derivative in the aforesaid method; and a device for the solid-phase synthesis of a glycopeptide.

    专利号:WO-0206209-A1
    优先权日:2000-07-19
    标 题 :Synthesis method for n1,n3-bis (2.aminoethyl) propane-1,3-diamine, synthesis intermediates, resulting products and use thereof in synthesis of cyclam
    发明人:HANDEL HENRI; BERNARD HELENE; ANTOINE MARINE
    权利人:UNIV BRETAGNE OCCIDENTALE; HANDEL HENRI; BERNARD HELENE; ANTOINE MARINE
    摘要:The invention concerns a method of synthesis of a linear polynitrogen-containing derivative, namely N1,N3-bis (2-aminoethyl) propane-1,3-diamine of general formula (I) using as synthesis intermediates compounds (II) and (III). The invention also concerns the resulting products and their use in the synthesis of cyclic polynitrogen-containing derivatives such as cyclam.

    专利号:WO-9837078-A1
    优先权日:1997-02-20
    标题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The thiophenes are prepared by reaction of a substrate-bound primary or secondary amine with a thiophosgene equivalent and reaction of the resulting intermediate with an acceptor-substituted acetonitrile in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegler-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:WO-2023012709-A1
    优先权日:2021-08-05
    标 题 :An improved process for fmoc synthesis of semaglutide
    发明人:LOBO LESTER JOHN; CHANDRAKESAN MURALIDHARAN; DOSHI CHETAN; CHANADAK SHAILESH LALCHAND; YADAV NANDLAL GOPAL; MOHE NIKHIL UMESH; VISHWANATHAN KODANDARAMAN
    权利人:USV PRIVATE LTD
    摘要:The present invention relates to an improved process for the synthesis of glucagon-like-peptide-1 (GLP-1) and its analogs by using combination of solid and solution phase synthesis of Fmoc protected amino acids in a sequential manner, optionally incorporating Boc protected dipeptide for unnatural amino acid in the Sequence of GLP-1, cleaving GLP-1 sequence from the resin followed by purification; attaching side-chain to the desired amino acid in the solution phase to synthesize desired GLP-1 analog, purifying it to Semaglutide. Temperature gradient is applied during initial coupling of amino acids to facilitate completion of difficult coupling reactions.

    专利号:US-7294486-B2
    优先权日:2001-09-05
    标 题:Enzymatic process for the synthesis of organo-fluorine compounds
    发明人:O'HAGAN DAVID; SCHAFFRATH CHRISTOPH
    权利人:UNIV ST ANDREWS
    摘要:There is described a process for the synthesis of a fluoronucleoside compound, said process comprising mixing a substrate and an enzyme from Streptomyces cattelya as catalyst. The process may be used to produce an 18 F labelled fluoronucleoside compound. There is also described an enzyme derived from Streptomyces cattelya which has the capacity to catalyse the synthesis of a fluoronucleoside compound.

    专利号:US-2004138469-A1
    优先权日:2002-12-23
    标 题 :Process for the synthesis of torsemide, in particular of pure and stable form II
    发明人:LUSSANA MASSIMILIANO; RAINONI MAURO; GAMBUZZA FILIPPO
    权利人:COSMA S P A
    摘要:The present invention relates to a new process for the synthesis of torsemide, in particular of pure and stable form II, which comprises direct synthesis of torsemide from 4-(3-methylphenylamino)-3-pyridine-sulphonamide. The new process envisages fewer steps than the processes described in the prior art, with improved yields and good quality from the chemical and preferably polymorphous points of view.
    陕西绿清生物工程有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sxgreenfine.com
    电话: 0086 (29) 8621-5910/20/30👤
    📞陕西绿清生物工程有限公司 ⚠️参考联系方式

    销售电话:0086 (29) 8621-5910/20/30
    邮箱:sarali@sxgreenfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:西安市凤城一路177号鼎新花园A5404
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    金隆制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemill.com
    电话: 00852-21919580👤
    📞金隆制药有限公司 ⚠️参考联系方式

    销售电话:00852-21919580
    邮箱:chemille@netvigator.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京梅尔森医药技术开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjmerson.com
    电话: 086-10-80484574,80483447👤
    📞北京梅尔森医药技术开发有限公司 ⚠️参考联系方式

    销售电话:086-10-80484574,80483447
    邮箱:sales@bjmerson.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都健腾生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aktinchem.com
    电话: 86-28-85159085👤
    📞成都健腾生物技术有限公司 ⚠️参考联系方式

    销售电话:86-28-85159085
    邮箱:info@aktinchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都博瑞特化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aikeshiji.com
    企业联系电话:4008-755-333👤
    📞成都博瑞特化学技术有限公司 ⚠️参考联系方式
    联系人:曹先生
    电话:4008-755-333
    手机:18080918076
    传真:QQ: 800078821
    邮箱:1312936220@qq.com
    通信地址: 成都市锦江区静宁路9号
    邮编: 610000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:成都市锦江区静宁路9号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Nur S, Adams CE. Chlorpromazine versus reserpine for schizophrenia. Cochrane Database Syst Rev. 2016 Apr 28;4:CD012122. doi: 10.1002/14651858.CD012122.pub2. Review. doi: 10.1016/j.neuint.2015.04.005. Epub 2015 Apr 29. doi: 10.1016/j.pnpbp.2014.10.009. Epub 2014 Nov 8. doi: 10.1002/14651858.CD007655.pub3. Review. doi: 10.1021/ol400046n. Epub 2013 Jan 18.
    6: Begum S, Naqvi SQ, Ahmed A, Tauseef S, Siddiqui BS. Antimycobacterial and antioxidant activities of reserpine and its derivatives. Nat Prod Res. 2012;26(22):2084-8. doi: 10.1080/14786419.2011.625502. Epub 2012 Jan 25. doi: 10.1016/j.jpba.2016.03.051. Epub 2016 Mar 25. doi: 10.1016/j.pbb.2010.11.021. Epub 2010 Dec 9. doi: 10.1016/j.bbr.2012.03.008. Epub 2012 Mar 16. doi: 10.1038/aps.2010.74.
    13: Barcan GA, Patel A, Houk KN, Kwon O. A torquoselective 6π electrocyclization approach to reserpine alkaloids. Org Lett. 2012 Nov 2;14(21):5388-91. doi: 10.1021/ol302265z. Epub 2012 Oct 5.

    合成参考文献


    参考文献:10.1186/1741-7015-8-13
    摘要:Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Medicine. 2010 Feb 15;8(1):13. doi: 10.1186/1741-7015-8-13.
    参考文献:10.1186/1746-4269-6-8
    摘要:Simbo DJ. An ethnobotanical survey of medicinal plants in Babungo, Northwest Region, Cameroon. Journal of Ethnobiology and Ethnomedicine. 2010 Feb 15;6(1):8. doi: 10.1186/1746-4269-6-8.
    参考文献:10.1007/s10886-011-9991-7
    摘要:Abreu IN, Ahnlund M, Moritz T, Albrectsen BR. UHPLC-ESI/TOFMS Determination of Salicylate-like Phenolic Gycosides in Populus tremula Leaves. Journal of Chemical Ecology. 2011 Jul 06;37(8):857. doi: 10.1007/s10886-011-9991-7.
    参考文献:10.1021/jm200370y
    摘要:Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. J Med Chem. 2011 Aug 25;54(16):5722–36. doi: 10.1021/jm200370y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知